Vironexis Biotherapeutics

Austin, TX · Founded 2021 · Privately Held (backing)

Developer of a cancer treatment biotechnology designed to offer AAV-delivered T-cell Immunotherapy. Vironexis Biotherapeutics is based in Austin, TX and was founded in 2021. Its last reported valuation was $125 million in Feb 2025. It has raised $52 million.

Last reported valuation
$125.0M
Oct 2026
Priced at
—
Total raised
$52.0M
Last round
—

Who backs Vironexis Biotherapeutics?

6 investors
InvestorType
Capital FactoryOther
Drive CapitalVenture capital
Future Ventures (San Francisco)Venture capital
Rev1 VenturesVenture capital
Moonshots CapitalVenture capital
Endo Investors—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Vironexis Biotherapeutics investors

6 investors are on record for Vironexis Biotherapeutics, including Capital Factory, Drive Capital, Future Ventures (San Francisco) and Rev1 Ventures.

Free account
More of Vironexis Biotherapeutics with a free account
  • ·Watch Vironexis Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Vironexis Biotherapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View